Evidence map›Paper›PMID 41012302›Full record

ArticlePolymers2025

Thermal and Mechanical Performance of Maleic Anhidride/Benzoyl Peroxide-Modified PLA/PCL Biocomposites.

Aritz Unamuno Garay, Alexandra Llidó Barragán, Santiago Ferrandiz-Bou, Maria Dolores Samper

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aritz Unamuno GarayDepartment of Mechanical and Materials Engineering, Universitat Politècnica de València (UPV), Plz. Ferrándiz y Carbonell, s/n, 03801 Alcoy, Spain.ORCID 0009-0008-4203-7801
Alexandra Llidó BarragánDepartment of Mechanical and Materials Engineering, Universitat Politècnica de València (UPV), Plz. Ferrándiz y Carbonell, s/n, 03801 Alcoy, Spain.ORCID 0009-0006-4847-8048
Santiago Ferrandiz-BouDepartment of Mechanical and Materials Engineering, Universitat Politècnica de València (UPV), Plz. Ferrándiz y Carbonell, s/n, 03801 Alcoy, Spain.ORCID 0000-0001-7137-9298
Maria Dolores SamperDepartment of Mechanical and Materials Engineering, Universitat Politècnica de València (UPV), Plz. Ferrándiz y Carbonell, s/n, 03801 Alcoy, Spain.ORCID 0000-0002-5102-8412

Funding

Agencia Estatal de Investigación TED2021-129920A-C43MCIN/AEI/10.13039/501100011033 PID2021-123753NA-C33
6 · The paper itself

Abstract

This study investigated PLA/PCL blends modified with maleic anhydride (MA) via radical grafting using benzoyl peroxide (BPO) as an initiator. Different formulations with 5 and 10 wt.% of PLA-g-MA (containing 1, 3, and 5 wt.% MA) were prepared to evaluate their compatibilizing effect. Samples were characterized thermally, mechanically, and morphologically using DSC, TGA, FTIR, goniometry, SEM, and tensile, impact, and hardness tests. The results show that adding PCL significantly improves the ductility of PLA, though it reduces tensile strength and hardness. Grafting with MA partially improves phase compatibility, as seen by increased elongation at break and impact resistance, especially at intermediate MA concentrations (1-3%). However, higher MA contents lead to greater variability in thermal and mechanical results, likely due to heterogeneous phase dispersion. FTIR analysis detected residual BPO in some formulations, though below 0.1 phr. TGA indicated a slight improvement in thermal stability at 5 wt.% MA. Overall, the findings suggest that controlled use of MA as a compatibilizer enhances the balance of mechanical and thermal properties in PLA/PCL systems.

Indexed as

benzoyl peroxidecompatibilizersmaleic anhydridePLA/PCL blend

Identifiers

PMID41012302
PMCPMC12473204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.